Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Management is confident in a $16 billion pipeline, up from $3 billion two years ago. Orion won a...
— Mike Collins, Matt Clarke, Chase McIntosh, Carl Wiese
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Orion Group
No other institutional pitches found for this ticker yet.
More institutional theses from GROW Funds
Lead drug ZUNVEYL was FDA approved in July 2024 for Alzheimer's treatment. It is only...
Top performer serving defense, space, and energy markets. Sells critical propulsion...
Strong performer throughout 2025. Positive operational improvements...